Abstract
We previously demonstrated that cells can be killed through transfection of an expression plasmid that encodes the diphtheria toxin A-chain fragment (DT-A). This report describes the construction of expression plasmids containing three mutant DT-A-coding sequences substituting glutamic acid 148 with aspartic acid, serine, or glutamine which are known to have 100- to 300-fold-reduced ADP-ribosylation activity measured in vitro. The toxicity of these constructs was determined in cotransfection experiments using HeLa and 293 cells with a luciferase expression plasmid as the reporter. Dose responses were compared for the three new DT-A mutant plasmids and for the corresponding plasmids containing wild-type DT-A and the previously characterized tox 176 mutant. The dose required to produce 50% inhibition of control luciferase expression in 293 embryonic kidney cells for the five plasmids ranged from 0.01 μg for wild-type DT-A to 1.2 μg for the least toxic plasmid, which replaces glutamic acid 148 with glutamine. In conclusion, a wide range of DT-A toxicity can be achieved by using plasmid expression vectors that encode different DT-A mutations.
Cite
CITATION STYLE
Fisher, K. S., Maxwell, I. H., Murphy, J. R., Collier, J., & Glode, L. M. (1991). Construction and expression of plasmids containing mutated diphtheria toxin A-chain-coding sequences. Infection and Immunity, 59(10), 3562–3565. https://doi.org/10.1128/iai.59.10.3562-3565.1991
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.